Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 16 | 2025 | 84 | 3.480 |
Why?
|
| Immunotherapy, Adoptive | 12 | 2025 | 844 | 1.420 |
Why?
|
| Neuroblastoma | 10 | 2025 | 534 | 1.040 |
Why?
|
| Interleukin-15 | 5 | 2025 | 90 | 0.820 |
Why?
|
| Galactosylceramides | 5 | 2018 | 15 | 0.800 |
Why?
|
| Neoplasms | 4 | 2025 | 2814 | 0.750 |
Why?
|
| Lymphocyte Activation | 9 | 2023 | 669 | 0.640 |
Why?
|
| Adjuvants, Immunologic | 4 | 2012 | 377 | 0.610 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 1154 | 0.440 |
Why?
|
| Glypicans | 2 | 2024 | 40 | 0.380 |
Why?
|
| Respiratory Mucosa | 1 | 2011 | 97 | 0.340 |
Why?
|
| HIV Antigens | 1 | 2009 | 11 | 0.300 |
Why?
|
| AIDS Vaccines | 1 | 2009 | 30 | 0.300 |
Why?
|
| Interleukins | 2 | 2020 | 119 | 0.290 |
Why?
|
| Cytotoxicity, Immunologic | 5 | 2023 | 255 | 0.280 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2025 | 10 | 0.230 |
Why?
|
| Gangliosides | 3 | 2025 | 66 | 0.230 |
Why?
|
| Animals | 20 | 2025 | 33094 | 0.220 |
Why?
|
| Mice | 17 | 2025 | 17528 | 0.210 |
Why?
|
| Immunologic Memory | 1 | 2025 | 191 | 0.210 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2023 | 16 | 0.200 |
Why?
|
| Mice, Inbred NOD | 6 | 2023 | 285 | 0.200 |
Why?
|
| Cancer Vaccines | 2 | 2014 | 184 | 0.190 |
Why?
|
| Mice, SCID | 6 | 2023 | 560 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 638 | 0.180 |
Why?
|
| Administration, Intranasal | 3 | 2011 | 129 | 0.180 |
Why?
|
| Immunity, Mucosal | 3 | 2011 | 83 | 0.180 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 617 | 0.180 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 331 | 0.170 |
Why?
|
| L-Selectin | 2 | 2018 | 19 | 0.160 |
Why?
|
| Lymphoma, B-Cell | 2 | 2018 | 136 | 0.160 |
Why?
|
| Flow Cytometry | 2 | 2011 | 754 | 0.150 |
Why?
|
| Receptors, Antigen | 2 | 2016 | 33 | 0.140 |
Why?
|
| Th1 Cells | 1 | 2018 | 148 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2025 | 926 | 0.130 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1689 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2020 | 425 | 0.120 |
Why?
|
| Humans | 19 | 2025 | 125613 | 0.120 |
Why?
|
| Salmonella typhimurium | 1 | 2014 | 42 | 0.110 |
Why?
|
| Vaccines, Attenuated | 1 | 2014 | 173 | 0.110 |
Why?
|
| Cytokines | 4 | 2016 | 1313 | 0.100 |
Why?
|
| Cell Line, Tumor | 5 | 2025 | 3436 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 764 | 0.100 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2013 | 10 | 0.100 |
Why?
|
| Glycosphingolipids | 1 | 2012 | 10 | 0.100 |
Why?
|
| Interferon-gamma | 3 | 2010 | 513 | 0.090 |
Why?
|
| Macaca mulatta | 2 | 2010 | 481 | 0.090 |
Why?
|
| Macrophages | 2 | 2014 | 643 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 406 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 237 | 0.090 |
Why?
|
| Cell Separation | 1 | 2011 | 218 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 962 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2020 | 2383 | 0.080 |
Why?
|
| Neoplasm Transplantation | 3 | 2018 | 358 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 601 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2010 | 479 | 0.080 |
Why?
|
| Dendritic Cells | 2 | 2009 | 425 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1343 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2014 | 727 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2009 | 507 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2896 | 0.070 |
Why?
|
| Cell Line | 2 | 2014 | 2558 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2009 | 147 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 991 | 0.070 |
Why?
|
| Immunization | 1 | 2009 | 301 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2011 | 4495 | 0.070 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2007 | 60 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1219 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2009 | 677 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2020 | 452 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 994 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2009 | 265 | 0.060 |
Why?
|
| Vaccination | 1 | 2011 | 994 | 0.060 |
Why?
|
| HIV-1 | 1 | 2009 | 469 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2018 | 57 | 0.060 |
Why?
|
| Vaccines, Synthetic | 1 | 2007 | 312 | 0.060 |
Why?
|
| Papillomavirus Vaccines | 1 | 2007 | 110 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2009 | 869 | 0.060 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2025 | 61 | 0.060 |
Why?
|
| Antigen-Presenting Cells | 2 | 2016 | 132 | 0.060 |
Why?
|
| Female | 8 | 2024 | 67790 | 0.050 |
Why?
|
| Interleukin-2 | 2 | 2018 | 231 | 0.050 |
Why?
|
| Lung | 1 | 2011 | 1509 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2007 | 253 | 0.050 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2023 | 14 | 0.050 |
Why?
|
| Etanercept | 1 | 2023 | 43 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 33 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2007 | 742 | 0.050 |
Why?
|
| Apoptosis | 2 | 2020 | 1795 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 404 | 0.050 |
Why?
|
| Transduction, Genetic | 2 | 2014 | 281 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 275 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2007 | 762 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 201 | 0.040 |
Why?
|
| Monocytes | 1 | 2023 | 329 | 0.040 |
Why?
|
| Vidarabine | 1 | 2020 | 85 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2023 | 336 | 0.040 |
Why?
|
| Immunity | 1 | 2020 | 175 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2014 | 429 | 0.040 |
Why?
|
| Granzymes | 1 | 2018 | 44 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2020 | 417 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 4878 | 0.030 |
Why?
|
| Child | 3 | 2023 | 25015 | 0.030 |
Why?
|
| 4-1BB Ligand | 1 | 2014 | 11 | 0.030 |
Why?
|
| Antigens, CD1d | 1 | 2014 | 20 | 0.030 |
Why?
|
| CD28 Antigens | 1 | 2014 | 74 | 0.030 |
Why?
|
| Retroviridae | 1 | 2014 | 180 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 824 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2013 | 12 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 724 | 0.030 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2013 | 56 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 92 | 0.020 |
Why?
|
| Th1-Th2 Balance | 1 | 2012 | 8 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 721 | 0.020 |
Why?
|
| Chemokine CCL20 | 1 | 2012 | 15 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2012 | 113 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 98 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 678 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 246 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 215 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 328 | 0.020 |
Why?
|
| Male | 3 | 2024 | 61966 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 585 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 622 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2010 | 194 | 0.020 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2009 | 100 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 50 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 910 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 199 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 714 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 333 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 842 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3702 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 2316 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2009 | 437 | 0.020 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2007 | 21 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2007 | 43 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1543 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 1063 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2013 | 864 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1848 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 27263 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4295 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 2545 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 3591 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4419 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12334 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 14316 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 19904 | 0.010 |
Why?
|